Lantern Pharma Inc. (LTRN) PT Raised to $36 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts LTRN Hot Sheet
Price: $5.62 -1.58%
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
H.C. Wainwright analyst Michael King raised the price target on Lantern Pharma Inc. (NASDAQ: LTRN) to $36.00 (from $34.00) while maintaining a Buy rating.
You May Also Be Interested In
- L&T Technology Services Ltd. (LTTS:IN) PT Lowered to INR2,700 at JPMorgan
- Persistent Systems Ltd. (PSYS:IN) PT Lowered to INR3,700 at JPMorgan
- Pegavision Corp (6491:TT) PT Lowered to NT$525 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
